Nuzenio

Why Crispr Therapeutics

Why Crispr Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 8 publisher sources 100/100 entity strength

Latest news

CRISPR Therapeutics AG (CRSP) Stock Forecasts - Yahoo! Finance CanadaYahoo! Finance Canada · Wed, 05 Aug 2026 20:30:22 GMTWhy CRISPR Therapeutics (CRSP) Is Up 11.6% After CASGEVY Expansion And Pipeline Updates - And What's Next - simplywall.stsimplywall.st · Wed, 05 Aug 2026 04:44:10 GMTCrispr Therapeutics Posts "Quiet" Quarter as Casgevy Advances, SiRNA Data Readouts Near, RBC Says - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 15:49:54 GMTCRISPR Therapeutics Launches Clinical Trials of In Vivo Gene Editors for Hypertension, AATD - Precision Medicine OnlinePrecision Medicine Online · Tue, 04 Aug 2026 14:29:21 GMTCRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates - Zacks Investment ResearchZacks Investment Research · Tue, 04 Aug 2026 14:02:19 GMTCRISPR Therapeutics AG Stock 12‑Month Price Target Raised to $84.39, Implies 70% Upside - TradingViewTradingView · Tue, 04 Aug 2026 09:20:03 GMTCRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 22:45:04 GMTCRISPR Therapeutics AG reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 03 Aug 2026 21:38:37 GMT

Timeline

Wed, 05 Aug 2026 20:30:22 GMTCRISPR Therapeutics AG (CRSP) Stock Forecasts - Yahoo! Finance Canada
Wed, 05 Aug 2026 04:44:10 GMTWhy CRISPR Therapeutics (CRSP) Is Up 11.6% After CASGEVY Expansion And Pipeline Updates - And What's Next - simplywall.st
Tue, 04 Aug 2026 15:49:54 GMTCrispr Therapeutics Posts "Quiet" Quarter as Casgevy Advances, SiRNA Data Readouts Near, RBC Says - Yahoo Finance
Tue, 04 Aug 2026 14:29:21 GMTCRISPR Therapeutics Launches Clinical Trials of In Vivo Gene Editors for Hypertension, AATD - Precision Medicine Online
Tue, 04 Aug 2026 14:02:19 GMTCRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates - Zacks Investment Research
Tue, 04 Aug 2026 09:20:03 GMTCRISPR Therapeutics AG Stock 12‑Month Price Target Raised to $84.39, Implies 70% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Why Crispr Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.